Biotechnology
New tentative approval for Mylan Labs’ posaconazole drug
New tentative approval for Mylan Labs’ posaconazole drug
(!(posaconazole structure)(https://www.DrugPatentWatch.com/img/drug-structure/posaconazole.png))(//www.DrugPatentWatch.com/p/preview/generic-api/posaconazole?utm_medium=dpw_wp_blog&utm_campaign =dpw_wp_blog&utm_source=dpw_wp_blog) Posaconazole is the generic ingredient in three brand-name drugs marketed by Msd Merck Co, Merck Sharp Dohme, Par Steril Products, Schering, Hikma, Actavis Labs Fl Inc, Aet Pharma,…
Post New tentative approval for Mylan Labs’ posaconazole drug appeared the first time DrugPatentWatch – Making Better Decisions.
Comments are closed.
